Economic portfolio
Motilal Oswal BSE Healthcare ETF
MOTILAL Motilal Oswal Mutual Fund Sep 2022 — Sep 2026 40 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
40 priced months, Sep 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
53.2% now, 55.2% in Sep 2025 · highest 63.7%, lowest 53.2%
Companies held
138 now, 119 in Sep 2025 · largest single holding 12.3% of equity
How it trades: no clear lean toward recent winners or losers (score +0.02 over 33 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Bandhan BSE Healthcare Index FundBandhan · 137 shared100.0%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 44 shared85.2%
- EODWHFEdelweiss · 25 shared74.1%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared70.3%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared70.3%
- DSP Nifty Healthcare Index FundDSP · 20 shared70.3%
- Axis NIFTY Healthcare ETFAxis · 20 shared70.3%
- DSP Nifty Healthcare ETFDSP · 20 shared70.3%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- 01 Anlon Healthcare Limited +6,960
- 02 Shukra Pharmaceuticals Limited +6,002
- 03 Gennex Laboratories Ltd +4,816
- 04 TAKE Limited +4,122
- 05 Ambalal Sarabhai Enterprise Ltd. +1,409
- 06 Ind-Swift Laboratories Limited +1,357
- 07 Medico Remedies Limited +902
- 08 Gaudium IVF and Women Health Limited +588
- 09 Amrutanjan Health Care Limited +424
- 10 Sai Parenterals Limited +332
Complete exits
Largest increases
- 01 Rubicon Research Limited+114.5% +985
- 02 Krishna Institute of Medical Sciences Limited+8.3% +567
- 03 Park Medi World Limited+32.9% +506
- 04 Sun Pharmaceutical Industries Limited+1.6% +465
- 05 Nephrocare Health Services Limited+66.5% +403
- 06 CORONA Remedies Limited+214.3% +360
- 07 Laurus Labs Limited+3.1% +325
- 08 Max Healthcare Institute Limited+1.6% +319
- 09 Piramal Pharma Limited+1.7% +297
- 10 Aster DM Quality Care Limited+3.9% +281
Largest reductions
- 01 Anthem Biosciences Limited-22.6% -869
- 02 Torrent Pharmaceuticals Limited-16.2% -635
- 03 Eris Lifesciences Limited-14.5% -243
- 04 Biocon Limited-0.2% -39
- 05 Jagsonpal Pharmaceuticals Limited-7.4% -38
- 06 IOL Chemicals and Pharmaceuticals Limited-1.0% -32
- 07 Natco Pharma Limited-0.4% -11
- 08 Windlas Biotech Limited-1.4% -3
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 12.32% | 5.46 Cr | 30,082 | by Sep 2022 (40 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 7.44% | 3.30 Cr | 3,550 | by Sep 2022 (40 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.24% | 2.32 Cr | 2,844 | by Sep 2022 (40 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 4.84% | 2.15 Cr | 10,839 | by Sep 2022 (40 mo+) |
| Cipla Limited | Healthcare | Large Cap | 4.78% | 2.12 Cr | 15,756 | by Sep 2022 (40 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 4.72% | 2.09 Cr | 16,976 | by Sep 2022 (40 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 4.32% | 1.92 Cr | 20,609 | by Sep 2022 (40 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 3.56% | 1.58 Cr | 3,285 | by Sep 2022 (40 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 3.09% | 1.37 Cr | 6,752 | by Sep 2022 (40 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 2.90% | 1.29 Cr | 7,695 | by Sep 2022 (40 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.52% | 1.12 Cr | 14,514 | by Sep 2022 (40 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.19% | 0.97 Cr | 4,168 | by Sep 2022 (40 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 1.90% | 0.84 Cr | 1,632 | by Sep 2022 (40 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 1.82% | 0.81 Cr | 6,948 | by Sep 2022 (40 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 1.75% | 0.78 Cr | 3,107 | Sep 2023 (34 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 1.69% | 0.75 Cr | 3,887 | by Sep 2022 (40 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.63% | 0.72 Cr | 19,525 | by Sep 2022 (40 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.44% | 0.64 Cr | 2,206 | by Sep 2022 (40 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.30% | 0.58 Cr | 3,786 | Mar 2025 (17 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.24% | 0.55 Cr | 7,372 | by Sep 2022 (40 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.18% | 0.52 Cr | 7,529 | by Sep 2022 (40 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 1.16% | 0.51 Cr | 240 | by Sep 2022 (40 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 1.10% | 0.49 Cr | 2,309 | by Sep 2022 (40 mo+) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 1.06% | 0.47 Cr | 1,437 | by Sep 2022 (40 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.02% | 0.45 Cr | 1,253 | by Sep 2022 (40 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 0.96% | 0.43 Cr | 2,151 | by Sep 2022 (40 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 0.87% | 0.39 Cr | 142 | by Sep 2022 (40 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 0.81% | 0.36 Cr | 17,434 | Apr 2023 (38 mo) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 0.78% | 0.35 Cr | 1,936 | by Sep 2022 (40 mo+) |
| Shilpa Medicare Limited | Healthcare | Small Cap | 0.77% | 0.34 Cr | 3,270 | by Sep 2022 (40 mo+) |
| Granules India Limited | Healthcare | Small Cap | 0.76% | 0.34 Cr | 4,004 | by Sep 2022 (40 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 0.76% | 0.34 Cr | 2,472 | Apr 2023 (38 mo) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 0.75% | 0.33 Cr | 2,173 | Sep 2025 (11 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.71% | 0.31 Cr | 1,133 | by Sep 2022 (40 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 0.67% | 0.30 Cr | 1,845 | Apr 2026 (6 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 0.58% | 0.26 Cr | 2,983 | Apr 2026 (6 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.51% | 0.23 Cr | 2,219 | by Sep 2022 (40 mo+) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 0.51% | 0.23 Cr | 1,163 | Mar 2025 (17 mo) |
| Strides Pharma Science Limited | Healthcare | Small Cap | 0.47% | 0.21 Cr | 1,849 | by Sep 2022 (40 mo+) |
| Natco Pharma Limited | Healthcare | Small Cap | 0.47% | 0.21 Cr | 2,495 | by Sep 2022 (40 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 0.45% | 0.20 Cr | 4,477 | by Sep 2022 (40 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 0.45% | 0.20 Cr | 1,377 | by Sep 2022 (40 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 0.44% | 0.19 Cr | 5,286 | by Sep 2022 (40 mo+) |
| Marksans Pharma Limited | Healthcare | Small Cap | 0.43% | 0.19 Cr | 5,934 | by Sep 2022 (40 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 0.42% | 0.19 Cr | 1,415 | by Sep 2022 (40 mo+) |
| Poly Medicure Limited | Healthcare | Small Cap | 0.39% | 0.17 Cr | 1,045 | by Sep 2022 (40 mo+) |
| Indegene Limited | Healthcare | Small Cap | 0.38% | 0.17 Cr | 2,887 | Sep 2024 (23 mo) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 0.38% | 0.17 Cr | 1,429 | by Sep 2022 (40 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 0.37% | 0.16 Cr | 421 | by Sep 2022 (40 mo+) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 0.36% | 0.16 Cr | 2,947 | by Sep 2022 (40 mo+) |
| Caplin Point Laboratories Limited | Healthcare | Small Cap | 0.34% | 0.15 Cr | 551 | by Sep 2022 (40 mo+) |
| Aarti Pharmalabs Limited | Healthcare | Small Cap | 0.31% | 0.14 Cr | 1,440 | Sep 2023 (34 mo) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 0.30% | 0.13 Cr | 5,298 | Mar 2024 (29 mo) |
| Concord Biotech Limited | Healthcare | Small Cap | 0.29% | 0.13 Cr | 933 | Mar 2024 (29 mo) |
| Bliss GVS Pharma Limited | Not classified | Small Cap | 0.29% | 0.13 Cr | 1,835 | by Sep 2022 (40 mo+) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 0.29% | 0.13 Cr | 1,533 | by Sep 2022 (40 mo+) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 0.28% | 0.12 Cr | 222 | by Sep 2022 (40 mo+) |
| Yatharth Hospital & Trauma Care Services Limited | Healthcare | Small Cap | 0.27% | 0.12 Cr | 1,181 | Mar 2024 (29 mo) |
| Morepen Laboratories Limited | Not classified | Small Cap | 0.27% | 0.12 Cr | 9,618 | by Sep 2022 (40 mo+) |
| Alivus Life Sciences Limited | Not classified | Small Cap | 0.27% | 0.12 Cr | 855 | by Sep 2022 (40 mo+) |
| CORONA Remedies Limited | Not classified | Small Cap | 0.25% | 0.11 Cr | 528 | Apr 2026 (6 mo) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 0.24% | 0.11 Cr | 174 | by Sep 2022 (40 mo+) |
| Viyash Scientific Limited | Healthcare | Small Cap | 0.23% | 0.10 Cr | 4,382 | by Sep 2022 (40 mo+) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 0.23% | 0.10 Cr | 2,120 | Sep 2025 (11 mo) |
| Healthcare Global Enterprises Limited | Healthcare | Small Cap | 0.22% | 0.10 Cr | 1,456 | by Sep 2022 (40 mo+) |
| Senores Pharmaceuticals Limited | Healthcare | Small Cap | 0.22% | 0.10 Cr | 693 | Mar 2025 (17 mo) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 0.21% | 0.09 Cr | 1,730 | by Sep 2022 (40 mo+) |
| Akums Drugs and Pharmaceuticals Limited | Healthcare | Small Cap | 0.18% | 0.08 Cr | 965 | Mar 2025 (17 mo) |
| Kovai Medical Center & Hospital Limited | Not classified | Small Cap | 0.17% | 0.08 Cr | 128 | by Sep 2022 (40 mo+) |
| Sanofi India Limited | Not classified | Small Cap | 0.17% | 0.08 Cr | 250 | Sep 2024 (23 mo) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.16% | 0.07 Cr | 186 | Mar 2025 (17 mo) |
| Supriya Lifescience Limited | Healthcare | Small Cap | 0.15% | 0.07 Cr | 718 | by Sep 2022 (40 mo+) |
| Nephrocare Health Services Limited | Healthcare | Small Cap | 0.15% | 0.07 Cr | 1,009 | Apr 2026 (6 mo) |
| Suven Life Sciences Limited | Healthcare | Small Cap | 0.15% | 0.07 Cr | 2,060 | by Sep 2022 (40 mo+) |
| IOL Chemicals and Pharmaceuticals Limited | Not classified | Small Cap | 0.15% | 0.06 Cr | 3,108 | by Sep 2022 (40 mo+) |
| Blue Jet Healthcare Limited | Healthcare | Small Cap | 0.13% | 0.06 Cr | 1,055 | Mar 2024 (29 mo) |
| Park Medi World Limited | Healthcare | Small Cap | 0.13% | 0.06 Cr | 2,046 | Apr 2026 (6 mo) |
| Ind-Swift Laboratories Limited | Not classified | Small Cap | 0.12% | 0.05 Cr | 1,357 | Sep 2026 (1 mo) |
| Innova Captab Limited | Not classified | Small Cap | 0.12% | 0.05 Cr | 446 | Mar 2024 (29 mo) |
| Sun Pharma Advanced Research Company Limited | Healthcare | Small Cap | 0.12% | 0.05 Cr | 2,622 | by Sep 2022 (40 mo+) |
| Solara Active Pharma Sciences Limited | Not classified | Small Cap | 0.11% | 0.05 Cr | 679 | by Sep 2022 (40 mo+) |
| Artemis Medicare Services Limited | Not classified | Small Cap | 0.11% | 0.05 Cr | 1,367 | by Sep 2022 (40 mo+) |
| Kwality Pharmaceuticals Limited | Not classified | Small Cap | 0.10% | 0.05 Cr | 127 | Sep 2025 (11 mo) |
| FDC Limited | Not classified | Small Cap | 0.10% | 0.05 Cr | 1,361 | by Sep 2022 (40 mo+) |
| Indraprastha Medical Corporation Limited | Not classified | Small Cap | 0.10% | 0.04 Cr | 1,226 | by Sep 2022 (40 mo+) |
| Aarti Drugs Limited | Not classified | Small Cap | 0.10% | 0.04 Cr | 992 | by Sep 2022 (40 mo+) |
| Orchid Pharma Limited | Not classified | Small Cap | 0.10% | 0.04 Cr | 424 | Sep 2024 (23 mo) |
| SMS Pharmaceuticals Limited | Not classified | Small Cap | 0.09% | 0.04 Cr | 809 | by Sep 2022 (40 mo+) |
| Novartis India Limited | Not classified | Small Cap | 0.09% | 0.04 Cr | 200 | by Sep 2022 (40 mo+) |
| Venus Remedies Ltd. | Not classified | Small Cap | 0.09% | 0.04 Cr | 212 | Sep 2026 (1 mo) |
| Shukra Pharmaceuticals Limited | Not classified | Small Cap | 0.08% | 0.04 Cr | 6,002 | Sep 2026 (1 mo) |
| Advanced Enzyme Technologies Limited | Healthcare | Small Cap | 0.08% | 0.04 Cr | 1,310 | Apr 2023 (38 mo) |
| RPG Life Sciences Limited | Not classified | Small Cap | 0.08% | 0.04 Cr | 120 | by Sep 2022 (40 mo+) |
| Gujarat Themis Biosyn Limited | Not classified | Small Cap | 0.08% | 0.03 Cr | 880 | by Sep 2022 (40 mo+) |
| Gufic Biosciences Limited | Not classified | Small Cap | 0.07% | 0.03 Cr | 754 | by Sep 2022 (40 mo+) |
| Syncom Formulations (India) Limited | Not classified | Small Cap | 0.07% | 0.03 Cr | 12,833 | by Sep 2022 (40 mo+) |
| Unichem Laboratories Limited | Not classified | Small Cap | 0.07% | 0.03 Cr | 569 | by Sep 2022 (40 mo+) |
| Krsnaa Diagnostics Limited | Not classified | Small Cap | 0.06% | 0.03 Cr | 506 | by Sep 2022 (40 mo+) |
| Dishman Carbogen Amcis Limited | Not classified | Small Cap | 0.06% | 0.03 Cr | 1,791 | by Sep 2022 (40 mo+) |
| Fredun Pharmaceuticals Limited | Not classified | Small Cap | 0.06% | 0.03 Cr | 198 | Sep 2026 (1 mo) |
Half of its current holdings have been held for 40 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Anlon Healthcare Limited | Sep 2026 | ▲ New position | +6,960 |
| Shukra Pharmaceuticals Limited | Sep 2026 | ▲ New position | +6,002 |
| Gennex Laboratories Ltd | Sep 2026 | ▲ New position | +4,816 |
| TAKE Limited | Sep 2026 | ▲ New position | +4,122 |
| Nectar Lifesciences Limited | Sep 2026 | ▼ Complete exit | -2,558 |
| Ambalal Sarabhai Enterprise Ltd. | Sep 2026 | ▲ New position | +1,409 |
| Ind-Swift Laboratories Limited | Sep 2026 | ▲ New position | +1,357 |
| Rubicon Research Limited | Sep 2026 | ▲ Increasing | +985 |
| Medico Remedies Limited | Sep 2026 | ▲ New position | +902 |
| Anthem Biosciences Limited | Sep 2026 | ▼ Reducing | -869 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -635 |
| Gaudium IVF and Women Health Limited | Sep 2026 | ▲ New position | +588 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +567 |
| Park Medi World Limited | Sep 2026 | ▲ Increasing | +506 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +465 |
| Amrutanjan Health Care Limited | Sep 2026 | ▲ New position | +424 |
| Nephrocare Health Services Limited | Sep 2026 | ▲ Increasing | +403 |
| CORONA Remedies Limited | Sep 2026 | ▲ Increasing | +360 |
| Sai Parenterals Limited | Sep 2026 | ▲ New position | +332 |
| Kilitch Drugs (I) Ltd. | Sep 2026 | ▲ New position | +331 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +325 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +319 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +297 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +281 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +263 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +245 |
| Eris Lifesciences Limited | Sep 2026 | ▼ Reducing | -243 |
| Emcure Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +227 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +225 |
| Medicamen Biotech Ltd. | Sep 2026 | ▲ New position | +212 |
| Venus Remedies Ltd. | Sep 2026 | ▲ New position | +212 |
| Health X Platform Limited | Sep 2026 | ▼ Complete exit | -209 |
| Syncom Formulations (India) Limited | Sep 2026 | ▲ Increasing | +198 |
| Fredun Pharmaceuticals Limited | Sep 2026 | ▲ New position | +198 |
| Viyash Scientific Limited | Sep 2026 | ▲ Increasing | +188 |
| Jupiter Life Line Hospitals Limited | Sep 2026 | ▲ Increasing | +172 |
| Fischer Medical Ventures Limited | Sep 2026 | ▲ Increasing | +170 |
| Morepen Laboratories Limited | Sep 2026 | ▲ Increasing | +149 |
| One Global Service Provider Limited | Sep 2026 | ▲ New position | +142 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +112 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +105 |
| Sigachi Industries Limited | Sep 2026 | ▲ Increasing | +103 |
| Blue Jet Healthcare Limited | Sep 2026 | ▲ Increasing | +103 |
| Shree Ganesh Remedies Limited | Sep 2026 | ▼ Complete exit | -95 |
| Marksans Pharma Limited | Sep 2026 | ▲ Increasing | +92 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +91 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +88 |
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +69 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +65 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +64 |
| Granules India Limited | Sep 2026 | ▲ Increasing | +62 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +60 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +55 |
| Fabtech Technologies Limited | Sep 2026 | ▲ Increasing | +55 |
| Solara Active Pharma Sciences Limited | Sep 2026 | ▲ Increasing | +54 |
| Vijaya Diagnostic Centre Limited | Sep 2026 | ▲ Increasing | +53 |
| Shilpa Medicare Limited | Sep 2026 | ▲ Increasing | +51 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +49 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +48 |
| Metropolis Healthcare Limited | Sep 2026 | ▲ Increasing | +47 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +47 |
| NGL Fine-Chem Limited | Sep 2026 | ▲ New position | +46 |
| Indegene Limited | Sep 2026 | ▲ Increasing | +45 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +44 |
| Aarti Drugs Limited | Sep 2026 | ▲ Increasing | +41 |
| Sun Pharma Advanced Research Company Limited | Sep 2026 | ▲ Increasing | +40 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -39 |
| Jagsonpal Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -38 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +37 |
| Bliss GVS Pharma Limited | Sep 2026 | ▲ Increasing | +36 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +36 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +36 |
| Onesource Specialty Pharma Limited | Sep 2026 | ▲ Increasing | +35 |
| Jubilant Pharmova Limited | Sep 2026 | ▲ Increasing | +34 |
| Suven Life Sciences Limited | Sep 2026 | ▲ Increasing | +34 |
| Dr. Agarwal's Health Care Limited | Sep 2026 | ▲ Increasing | +33 |
| IOL Chemicals and Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -32 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +30 |
| Strides Pharma Science Limited | Sep 2026 | ▲ Increasing | +29 |
| Dishman Carbogen Amcis Limited | Sep 2026 | ▲ Increasing | +28 |
| Thyrocare Technologies Limited | Sep 2026 | ▲ Increasing | +27 |
| Bajaj Healthcare Limited | Sep 2026 | ▲ Increasing | +27 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +25 |
| Aarti Pharmalabs Limited | Sep 2026 | ▲ Increasing | +23 |
| Alembic Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +23 |
| Healthcare Global Enterprises Limited | Sep 2026 | ▲ Increasing | +23 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +22 |
| Rainbow Childrens Medicare Limited | Sep 2026 | ▲ Increasing | +22 |
| Artemis Medicare Services Limited | Sep 2026 | ▲ Increasing | +21 |
| FDC Limited | Sep 2026 | ▲ Increasing | +21 |
| Advanced Enzyme Technologies Limited | Sep 2026 | ▲ Increasing | +20 |
| Indraprastha Medical Corporation Limited | Sep 2026 | ▲ Increasing | +19 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +18 |
| Yatharth Hospital & Trauma Care Services Limited | Sep 2026 | ▲ Increasing | +18 |
| K M C Speciality Hospitals (India) Limited | Sep 2026 | ▲ Increasing | +17 |
| Hikal Limited | Sep 2026 | ▲ Increasing | +16 |
| Poly Medicure Limited | Sep 2026 | ▲ Increasing | +16 |
| Indoco Remedies Limited | Sep 2026 | ▲ Increasing | +16 |
| Akums Drugs and Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +15 |
| Concord Biotech Limited | Sep 2026 | ▲ Increasing | +15 |
Changes compare consecutive month-end disclosures for this portfolio only.